tVNS® is a transcutaneous vagus nerve stimulation device for the treatment of symptoms of sympathovagal imbalance. It is approved for epilepsy, autism, insomnia, tinnitus, cognitive impairment, depression and migraine. Changing the World Changing the Lives Elevate your health journey and discover a medication-free, low side effect and non-invasive therapy option for the treatment of neurological diseases. Time to meet a better version of your life. I'm a Patient I’m a Physician I’m a Researcher Become a Distributor Learn more about tVNS Health GmbH tVNS Health GmbH offers worldwide sales and solution services for tVNS® devices for the selected regions , ensuring widespread access to revolutionary neuromodulation treatments across the globe. To play, press and hold the enter key. To stop, release the enter key. tVNS® Devices are Trusted by Leading Institutions Worldwide Why We Lead in Vagus Nerve Stimulation? For over 20 years , our commitment to innovation has positioned us at the forefront of non-invasive vagus nerve stimulation. Our unmatched research and development efforts are backed by solid clinical trials, ensuring our devices are not only effective but also safe and reliable. As an approved Class IIa medical device under the EU-MDR , we offer scientifically validated solutions in a market crowded with unverified alternatives. Since introducing the Cerbomed Nemos® device, we’ve led the market in non-invasive vagus nerve technology. Our pioneering approach and sustained innovation keep us ahead, with our devices being preferred by healthcare professionals and researchers worldwide due to unmatched safety, reliability and precision. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients. Discover tVNS Patient Discover tVNS Research tVNS® In the Media To play, press and hold the enter key. To stop, release the enter key. tVNS® Healing Stories News from tVNS® tVNS Coma Symposium, Warsaw, Poland "tVNS therapy in Comatose Patients" has been a focus research area in recent years in collaboration with esteemed scientists from... Transcutaneous Vagus Nerve Stimulation (tVNS) in Autism. Pediatric neurology specialist Associate Professor Dr. Barış Ekici shares his insights and experiences with transcutaneous vagus nerve stimu Information on tVNS from PD Dr Ranni von Wrede and Dr Pukrowski from Klinik für Epileptologie, UKB Bonn PD. Dr. Ranni von Wrede and Dr. Pukrowski, leading epileptologists from the University of Bonn, discuss the concept of Transcutaneous... A real life epilepsy story of Elena : tVNS in West and Aicardi Syndrome Discover the inspiring journey of Elena, a young girl with Aicardi syndrome and drug-resistant epilepsy, and the positive impact of tVNS... A real life epilepsy story of Oguzhan: tVNS in Dravet Syndrome and Resistant Epilepsy Zeliha Korkmaz, the mother of 7-year-old Oğuzhan, who battles resistant epilepsy and was diagnosed with Dravet syndrome at 4.5 months... Inspiring Insights and 2 coma recovery cases from Prof. Dr. Halil Özcan on Vagus Nerve Stimulation Professor Dr. Halil Özcan, shares insights on his 2 years tVNS experience and 2 coma recovery testimonials Contact Our Global tVNS Experts Worldwide Name Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

Latest News Mar 17, 2023 5 most promising Fintech startups This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 21, 2023 Gadget review: release of new Airy Pods This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 22, 2023 Best smart wearables of 2023 This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 19, 2023 How technology can help curb attention disorders This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 18, 2023 Entering a new era of IoT This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 20, 2023 Long-term benefits of clean energy sources This is placeholder text. To change this content, double-click on the element and click Change Content. Read More

tVNS Health Gmbh is a medical technology sales company based in Grünwald, Germany, that has been responsible for the global distribution, services, and operations management of tVNS devices. tVNS® in Italy: tVNS Health GmbH tVNS Health GmbH is a medical technology sales company based in Germany, responsible for the global distribution, services, and sales of tVNS® non-invasive auricular vagus nerve stimulation devices in Eastern Europe, Scandinavia, Asia, Africa, South America and Italy. The developer and manufacturer of tVNS® devices is tVNS Technologies GmbH based in Erlangen, Germany. Since the medical approval of the Cerbomed Nemos® device as a first non-invasive auricular vagus nerve stimulation medical device in 2010, Cerbomed Nemos® and the new tVNS® have been used in thousands of treatments globally and significantly improved patients’ quality of life. tVNS Health GmbH Global Sales & Services: Südliche Münchner Str. 62, 82031 Grünwald, Germany info@tvns.health www.tvns.health Contact Us

Transform Patient Care with tVNS® Empower your practice and patients with a non-invasive solution that enhances well-being without the need for medication. With its precise cymba concha stimulation and wireless parameter flexibility, tVNS® offers cutting-edge technology and unparalleled flexibility to explore new therapeutic protocols. Approved under as a Class IIa medical device under the EU-MDR, our tVNS® device ensures adherence to the highest standards of safety and efficacy in medical research. tVNS® Devices are Trusted by Leading Institutions Worldwide To play, press and hold the enter key. To stop, release the enter key. tVNS® R for Research Transcutaneous Vagus Nerve Stimulation Device for Research Full Wireless Parameter Programmability Patient App for Data Collection Support for Clinical Trials Triggered tVNS® Legacy and Hook Electrode Sham Stimulation Key Benefits for Patients EU-MDR Cla ss IIa Certified Medical Device tVNS® is the world's only non-invasive vagus nerve stimulation approved as a Class IIa medical device under the EU-MDR, offering a scientifically validated treatment for conditions related to sympathovagal imbalance. Non-Invasive Approach A safe and gentle alternative to surgery and medication, tVNS® stimulates the vagus nerve through the skin, offering a harmonious path to wellbeing with very low side-effects. Most Effective Stimulation Site tVNS® is the only non-invasive stimulation device that stimulates the cymba concha, resulting in 100% vagus nerve innervation (as opposed to e.g. the tragus, which only results in 45% innervation). Minimal Side Effects Transitioning away from traditional medications often aims to reduce side effects. tVNS®, as a drug-free therapy, offers a safer alternative with lower risk of long-term adverse effects. Why We Lead in Vagus Nerve Stimulation? For over 20 years, our commitment to innovation has positioned us at the forefront of non-invasive vagus nerve stimulation. Our unmatched research and development efforts are backed by solid clinical trials, ensuring our devices are not only effective but also safe and reliable. As an approved Class IIa medical device under the EU-MDR, we offer scientifically validated solutions in a market crowded with unverified alternatives. Since introducing the Cerbomed Nemos® device, we’ve led the market in non-invasive vagus nerve technology. Our pioneering approach and sustained innovation keep us ahead, with our devices being preferred by healthcare professionals and researchers worldwide due to unmatched safety, reliability and precision. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients. Learn More About tVNS Health GmbH What is tVNS®? Elevating patient treatment options with non-invasive vagus nerve stimulation for the treatment of neurological diseases When traditional pharmacological or invasive treatments fall short or present challenging side effects, tVNS® offers an effective and patient-friendly treatment option. The vagus nerve, central to our body’s nervous system, plays a critical role in maintaining homeostasis. tVNS® , or Transcutaneous Vagus Nerve Stimulation , harnesses the therapeutic potential of this nerve through targeted stimulation of its auricular branch, accessible within the ear. This innovative approach utilizes gentle electrical impulses to modulate the vagus nerve’s activity, encouraging a state of balance across the body’s systems. The result? A reduction in the symptoms of neurological diseases associated with sympathovagal imbalance, achieved through a method that avoids the invasiveness of surgery and the side effects associated with medication. Approved as a Class IIa medical device under the European Medical Device Regulation (MDR), tVNS® sets a new standard in the treatment of neurological conditions, offering a blend of efficacy, safety, and simplicity. tVNS® is indicated to treat the following conditions: ✓Depression ✓Epilepsy ✓Chronic Migraines ✓Prader-Willi Syndrome Treatment with tVNS® is characterized by its simplicity and adaptability to everyday life. At its core, tVNS® operates on the principle of neurostimulation, a process that engages the vagus nerve’s capacity to influence various bodily functions and systems. tVNS® stimulates the auricular branch of the vagus nerve (ABVN) through the skin with gentle and precise electrical impulses that propagate therapeutic signals to the brain, first to the brain stem and then to higher centers, aiming to correct dysregulation within the nervous system. The application of tVNS® is designed with the patient in mind: it is easy, portable, and discreet, making it possible to incorporate treatment sessions into your schedule without interruption to your daily tasks. Whether you’re at home, in the office, or traveling, tVNS® provides a consistent and accessible means to manage symptoms of neurological disorders, including the reduction of seizure frequencies in epilepsy, among other conditions. Each session with the tVNS® device is a step towards rebalancing the nervous system, leveraging the natural pathways of the body to foster healing and symptom relief. The device’s ease of use ensures that starting and maintaining a regimen with tVNS® is straightforward, empowering users to take control of their health in a non-intrusive, effective manner. How does treatment with tVNS® work? Patients can use tVNS® anytime, anywhere. It's easy to use, portable, and discrete. Research and Patient App Your tVNS® R device gives you access to two apps: the tVNS® Research and tVNS® Patient app. All technical parameters can easily be reprogrammed and wirelessly transmitted with the tVNS® Research app, allowing the researcher to try completely new stimulation protocols. In addition, you can collect and store technical and patient data. The tVNS® Patient app automatically stores all technical data (stimulation parameters, time and duration of the stimulation etc.) and offers a questionnaire for patient feedback. tVNS® Patient is fully compliant with the General Data Protection Regulation (GDPR), ensuring that patient data is handled with the utmost care and confidentiality. Why choose our tVNS® devices? Our tVNS® device is the only non-invasive vagus nerve stimulator that is approved as a Class IIa medical device under the European Medical Device Regulation (EU-MDR). tVNS® sets itself apart with its non-invasive, clinically validated approach, offering a safer and more comfortable alternative to invasive methods. Uniquely targeting the cymba concha for 100% innervation of the auricular branch of the vagus nerve (ABVN) with our patented electrode, tVNS® ensures maximum efficacy compared to other devices that only achieve partial innervation. EU-MDR Cla ss IIa Approved Medical Device Our tVNS® device is the only non-invasive vagus nerve stimulation (VNS) device that is approved as a medical device under the EU-MDR. It uniquely targets the Cymba Concha for 100% innervation of the auricular branch of the vagus nerve, unlike other devices that stimulate other areas and are not manufactured under the same quality and safety standards. EU-MDR Cla ss IIa Non-Surgical Approach tVNS® offers the efficacy of vagus nerve stimulation without the complexities or risks of surgical interventions. This means meaningful therapeutic benefits, all under your patient's control, without invasive procedures. EU-MDR Cla ss IIa Minimal Side Effects Transitioning away from traditional medications often comes with the pursuit of fewer side effects. tVNS®, being drug-free, ensures a therapeutic experience with reduced potential for long-term adverse outcomes, positioning itself as a safer alternative. EU-MDR Cla ss IIa Made in Germany Our commitment to excellence ensures that each device meets the highest standards of quality and performance, embodying the renowned precision of German engineering and manufacturing. With tVNS®, you’re choosing a device built on a foundation of durability and innovative design, trusted by healthcare professionals and researchers worldwide. EU-MDR Cla ss IIa Innovative App Integration Tracking and understanding your treatment progression is crucial. Our dedicated tVNS® Patient App not only provides real-time monitoring but also facilitates seamless sharing of data with healthcare professionals. EU-MDR Cla ss IIa Remote Flexibility In our modern age, the convenience of remote access is invaluable. tVNS® extends this by offering device delivery directly to your patient's doorstep and remote training. Your patient can initiate their treatment journey without the hassles or constraints of travel. Easy to Use Functionality should not compromise simplicity. The tVNS® device, while technologically advanced, is as intuitive as a smartphone, making integration into daily routines effortless. Clinical Evidence: The Science behind tVNS® Discover the proven effectiveness and safety of tVNS®, highlighted by pivotal clinical trials and studies. Our unique focus on cymba concha stimulation, quality control and clinical evidence, positions tVNS® as the preferred choice among researchers, ensuring we lead in neurotherapeutic innovation and patient care. Epilepsy After a 20 week treatment period, active tVNS® patients recorded an average 34.2% reduction of seizure frequency. Prader-Willi-Syndrome After a treatment period of 12 months, 80% of tVNS® patients recorded a reduction of mean number of outbursts per day of 50%, compared to mean number of outburst per day before treatment. Migraines Treatment with tVNS® led to a reduction of 50% of the frequency of days with migraines after a treatment period of 12 weeks. Depression tVNS® led to a reduction of depression-specific HAMD score of minimum 2-3 points in adult patients when used in parallel with psychopharmacological and psychotherapy treatments after a period of 9 weeks. tVNS Healing Stories Take the Next Step in Patient Care with tVNS® Discover the potential of tVNS® to transform the treatment landscape for your patients. Embrace a solution that offers a safe, non-invasive pathway to relief, especially for those who have explored conventional treatments without success. Join us in leading the way towards innovative, compassionate care. Connect with our qualified experts today to learn more about integrating tVNS® into your practice and how it can benefit your patients. Together, let’s pave the path to better health and improved quality of life. Name : Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

tVNS® vagus therapy devices offer a non-surgical neuromodulation treatment option by providing auricular vagus nerve stimulation in difficult-to-treat brain diseases with the help of a smartphone-sized device and a special electrode. tVNS® Devices for Patients Be a part of your success story Buy tVNS Better days are ahead EU-MDR Cla ss IIa Certified Medical Device tVNS® is the world's only non-invasive vagus nerve stimulation approved as a Class IIa medical device under the EU-MDR, offering a scientifically validated treatment for conditions related to sympathovagal imbalance. Non-Invasive Approach A safe and gentle alternative to surgery and medication, tVNS® stimulates the vagus nerve through the skin, offering a harmonious path to wellbeing with very low side-effects. Most Effective Stimulation Site Minimal Side Effects tVNS® is the only non-invasive stimulation device that stimulates the cymba concha, resulting in 100% vagus nerve innervation (as opposed to e.g. the tragus, which only results in 45% innervation). Transitioning away from traditional medications often aims to reduce side effects. tVNS®, as a drug-free therapy, offers a safer alternative with lower risk of long-term adverse effects. tVNS® In the Media To play, press and hold the enter key. To stop, release the enter key. What is tVNS®? Navigating the world of medical treatments can be overwhelming, especially when faced with persistent and challenging health issues. Whether you’ve been tirelessly seeking effective solutions, or if traditional drug therapies have been unsuccessful, there is another option: tVNS® . The vagus nerve, central to our body’s nervous system, plays a critical role in maintaining homeostasis. tVNS®, or Transcutaneous Vagus Nerve Stimulation , harnesses the therapeutic potential of this nerve through targeted stimulation of its auricular branch, accessible within the ear. This innovative approach utilizes gentle electrical impulses to modulate the vagus nerve’s activity, encouraging a state of balance across the body’s systems. The result? A reduction in the symptoms of neurological diseases associated with sympathovagal imbalance, achieved through a method that avoids the invasiveness of surgery and the side effects associated with medication. Approved as a Class IIa medical device under the European Medical Device Regulation (MDR), tVNS® sets a new standard in the treatment of neurological conditions, offering a blend of efficacy, safety, and simplicity. Non-invasive vagus nerve stimulation for the treatment of neurological diseases tVNS® is indicated to treat the following conditions: ✓Depression ✓Epilepsy ✓Chronic Migraines ✓Prader-Willi Syndrome tVNS® Devices are Trusted by Leading Institutions Worldwide To play, press and hold the enter key. To stop, release the enter key. Why choose our tVNS® devices? Our tVNS® device is the only non-invasive vagus nerve stimulator that is approved as a Class IIa medical device under the European Medical Device Regulation (EU-MDR). tVNS® sets itself apart with its non-invasive, clinically validated approach, offering a safer and more comfortable alternative to invasive methods. Uniquely targeting the cymba concha for 100% innervation of the auricular branch of the vagus nerve (ABVN) with our patented electrode, tVNS® ensures maximum efficacy compared to other devices that only achieve partial innervation. EU-MDR Cla ss IIa Approved Medical Device Our tVNS® device is the only non-invasive vagus nerve stimulation (VNS) device that is approved as a medical device under the EU-MDR. It uniquely targets the Cymba Concha for 100% innervation of the auricular branch of the vagus nerve, unlike other devices that stimulate other areas and are not manufactured under the same quality and safety standards. EU-MDR Cla ss IIa Non-Surgical Approach tVNS® offers the efficacy of vagus nerve stimulation without the complexities or risks of surgical interventions. This means meaningful therapeutic benefits, all under your control, without invasive procedures. EU-MDR Cla ss IIa Minimal Side Effects Transitioning away from traditional medications often comes with the pursuit of fewer side effects. tVNS®, being drug-free, ensures a therapeutic experience with reduced potential for long-term adverse outcomes, positioning itself as a safer alternative. EU-MDR Cla ss IIa Made in Germany Our commitment to excellence ensures that each device meets the highest standards of quality and performance, embodying the renowned precision of German engineering and manufacturing. With tVNS®, you’re choosing a device built on a foundation of durability and innovative design, trusted by healthcare professionals and researchers worldwide. EU-MDR Cla ss IIa Innovative App Integration Tracking and understanding your treatment progression is crucial. Our dedicated tVNS® Patient App not only provides real-time monitoring but also facilitates seamless sharing of data with your healthcare professionals. EU-MDR Cla ss IIa Remote Flexibility In our modern age, the convenience of remote access is invaluable. tVNS® extends this by offering device delivery directly to your doorstep and remote training. Initiate your treatment journey without the hassles or constraints of travel. Easy to Use Functionality should not compromise simplicity. The tVNS® device, while technologically advanced, is as intuitive as a smartphone, making integration into daily routines effortless. How does tVNS® work? tVNS ® Patient Devices - tVNS ® E tVNS® vagus therapy devices offer a non-surgical neuromodulation treatment option by providing auricular vagus nerve stimulation in difficult-to-treat brain diseases with the help of a smartphone-sized device and a special electrode. With its innovative mobile application, the patient can share all the treatment information with a single click without leaving his home, and reach the necessary follow-up and support. tVNS® stimulates the branch of the vagus nerve in the auricle through the skin with gentle electrical impulses. Signals are passed on to the brain via special nerve fibers: first in the brain stem and then in higher centers. The treatment with tVNS® is applied by patients independently. It has been used by thousands of patients and is a treatment with very few side effects. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients Download the tVNS® Patient App The innovative tVNS® Patient App is a wellness and session-diary application designed to help users keep a record of their well-being and the duration of their stimulation sessions. The tVNS® Patient App is available now in the Google Play Store and in the Apple App Store (EU-only). tVNS® Patient is fully compliant with the General Data Protection Regulation (GDPR), ensuring that patient data is handled with the utmost care and confidentiality. Clinical Evidence: The Science behind tVNS® Discover the proven effectiveness and safety of tVNS®, highlighted by pivotal clinical trials and studies. Our unique focus on cymba concha stimulation, quality control and clinical evidence, positions tVNS® as the preferred choice among researchers, ensuring we lead in neurotherapeutic innovation and patient care. Epilepsy After a 20 week treatment period, active tVNS® patients recorded an average 34.2% reduction of seizure frequency. Prader-Willi-Syndrome After a treatment period of 12 months, 80% of tVNS® patients recorded a reduction of mean number of outbursts per day of 50%, compared to mean number of outburst per day before treatment. Migraines Treatment with tVNS® led to a reduction of 50% of the frequency of days with migraines after a treatment period of 12 weeks. Depression tVNS® led to a reduction of depression-specific HAMD score of minimum 2-3 points in adult patients when used in parallel with psychopharmacological and psychotherapy treatments after a period of 9 weeks. tVNS Healing Stories Take the next step with tVNS® - for a life without limitations. Every day presents an opportunity. Yet, for those navigating the challenges of medical conditions, some days can feel overshadowed by discomfort or uncertainty. With tVNS® , we aim to bring a brighter shade to every day. By harnessing the power of neurostimulation, our tVNS® device aims to pave the way for more pain-free days, empowering patients to lead self-determined lives. It’s not merely about symptom relief, it’s about reclaiming the essence of each day, savoring moments with loved ones, and pursuing passions without being held back by your condition. tVNS® is approved for the treatment of the following indications. Anxiety Atrial Fibrillation Autism Cognitive Impairment Crohn's disease (IBD) Depression Epilepsy Migraine Parkinson's Prader-Willi Syndrome Sleeping disorders Systematic Sclerosis Tinnitus Contact Our Global tVNS Experts Worldwide Name : Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting! Contact Our Global tVNS Experts Worldwide Name : Select inquiry Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

Our Services This is your Services Page. It's a great opportunity to provide information about the services you provide. Double click on the text box to start editing your content and make sure to add all the relevant details you want to share with site visitors. Whether you're offering multiple services, courses or programs, you can edit this space to fit your website's needs. Simply double click on this section to open the content manager and modify the content. Explain what each item entails and add photos or videos for even more engagement. Service Name I'm a paragraph. Click here to add your own text and edit me. It’s easy. Service Name I'm a paragraph. Click here to add your own text and edit me. It’s easy. Service Name I'm a paragraph. Click here to add your own text and edit me. It’s easy. Service Name I'm a paragraph. Click here to add your own text and edit me. It’s easy. Get a Quote This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content. First Name Last Name Email Send Thanks for submitting!

Contact Us This is your Contact section paragraph. Encourage your reader to reach out with any questions, comments or to take a different action specific to your site. 500 Terry Francine Street, San Francisco, CA 94158 info@mysite.com 123-456-7890 First Name Last Name Email Message Send Thanks for submitting! Facebook Twitter Instagram Linkedin Opening Hours Mon - Fri 8:00 am – 8:00 pm Saturday 9:00 am – 7:00 pm Sunday 9:00 am – 9:00 pm

Contact Us This is your Contact section paragraph. Encourage your reader to reach out with any questions, comments or to take a different action specific to your site. 500 Terry Francine Street, San Francisco, CA 94158 info@mysite.com 123-456-7890 First Name Last Name Email Message Send Thanks for submitting! Facebook Twitter Instagram Linkedin Opening Hours Mon - Fri 8:00 am – 8:00 pm Saturday 9:00 am – 7:00 pm Sunday 9:00 am – 9:00 pm

< Back Long-term benefits of clean energy sources Kim Jennings Mar 20, 2023 This is placeholder text. To change this content, double-click on the element and click Change Content. This is placeholder text. To change this content, double-click on the element and click Change Content. Want to view and manage all your collections? Click on the Content Manager button in the Add panel on the left. Here, you can make changes to your content, add new fields, create dynamic pages and more. Your collection is already set up for you with fields and content. Add your own content or import it from a CSV file. Add fields for any type of content you want to display, such as rich text, images, and videos. Be sure to click Sync after making changes in a collection, so visitors can see your newest content on your live site. Previous Next

Distributor Services tVNS Health GmbH offers: Access to tVNS Neuromodulation Academy: for training of the new distributors on tVNS devices and transcutaneous vagal neuromodulation Support on local marketing, sales training and go-to-market strategy Support on onboarding activities . Become a tVNS Distributor

Contains information about tVNS clinical research devices tVNS® R for Research Discover a Revolutionary Journey with Innovative tVNS® Research Device Meet the cutting-edge realm of vagus nerve stimulation research, where innovation meets precision in our state-of-the-art tVNS® R device. Crafted for flexibility and accuracy, it boasts complete wireless programmability, making it the perfect companion for in-depth clinical studies. Experience seamless control with the tVNS® Research and tVNS® Patient apps, integrating stimulation parameter adjustments, data collection, and patient feedback to elevate the depth and precision of your research. Our commitment extends beyond technology; we're here to streamline your clinical trials, providing robust support for your studies, including a thorough CB safety report for swift ethics approvals and access to a global network of experts. Uncover the limitless potential of tVNS® R as it pioneers revolutionary paths in neurological research and transforms the landscape of patient care. Your journey to groundbreaking discoveries starts here. tVNS® R for Research Transcutaneous Vagus Nerve Stimulation Device for Research Full Wireless Parameter Programmability Patient App for Data Collection Support for Clinical Trials Triggered tVNS® Legacy and Hook Electrode Sham Stimulation Research and Patient App Your tVNS® R device gives you access to two apps: the tVNS® Research and tVNS® Patient app. All technical parameters can easily be reprogrammed and wirelessly transmitted with the tVNS® Research app, allowing the researcher to try completely new stimulation protocols. In addition, you can collect and store technical and patient data. The tVNS® Patient app automatically stores all technical data (stimulation parameters, time and duration of the stimulation etc.) and offers a questionnaire for patient feedback. Support for Clinical Trials We offer an individual adaptation of all parts for certain studies, e.g by changing the questionnaire in order to allow better feedback from the patient, or through the implementation of special stimulation parameters or technical ideas. The tVNS® R device is defined as a device for investigational use. We can provide a CB report that proves the safety according to all medical device standards, in order to assist you with ethics approvals. So far, it has been accepted by all ethics committees. In addition, we offer an international expert network and can direct any questions to experienced people around the world. Triggered tVNS® We offer a separate PC-based tVNS® manager software. This software enables reaction to outside trigger signals (e.g. ECG R-wave trigger generated by an external ECG system, transferred to a PC). Thus, closed loop tVNS® or triggered tVNS® can be realized in a scientific setup. Legacy and Hook Electrode We offer two different types of electrode designs with our tVNS® devices: The Hook Electrode (left) comes standard with all new tVNS® devices. It offers bet ter fixation and usability during daily activities. The Legacy Electrode (right) can be used if the patient has small ears or a special ear shape. The integrated slider allows for better adaption to the ear. Sham Stimulation The well known sham stimulation at the ear lobe is still possible. Upon request, we support studies by providing other more sophisticated sham stimulation options.

Pioneering Neuromodulation Research with tVNS® Discover why tVNS® is the preferred device for research on transcutaneous vagus nerve stimulation.With its precise cymba concha stimulation and wireless parameter flexibility, tVNS offers cutting-edge technology and unparalleled flexibility to explore new therapeutic protocols.Approved under the EU-MDR and backed by CB reports, our tVNS device ensures adherence to the highest standards of safety and efficacy in medical research. tVNS® R for Research Transcutaneous Vagus Nerve Stimulation Device for Research Full Wireless Parameter Programmability Patient App for Data Collection Support for Clinical Trials Triggered tVNS® Legacy and Hook Electrode Sham Stimulation tVNS® Devices are Trusted by Leading Institutions Worldwide To play, press and hold the enter key. To stop, release the enter key. Why We Lead in Vagus Nerve Stimulation? For over 20 years, our commitment to innovation has positioned us at the forefront of non-invasive vagus nerve stimulation. Our unmatched research and development efforts are backed by solid clinical trials, ensuring our devices are not only effective but also safe and reliable. As an approved Class IIa medical device under the EU-MDR, we offer scientifically validated solutions in a market crowded with unverified alternatives. Since introducing the Cerbomed Nemos® device, we’ve led the market in non-invasive vagus nerve technology. Our pioneering approach and sustained innovation keep us ahead, with our devices being preferred by healthcare professionals and researchers worldwide due to unmatched safety, reliability and precision. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients. Learn More About tVNS Health GmbH Why Choose our tVNS® Devices for Research? Our tVNS® device is the only non-invasive vagus nerve stimulator that is approved as a Class IIa medical device under the European Medical Device Regulation (EU-MDR). tVNS® sets itself apart with its non-invasive, clinically validated approach, offering a safer and more comfortable alternative to invasive methods. Uniquely targeting the cymba concha for 100% innervation of the auricular branch of the vagus nerve (ABVN) with our patented electrode, tVNS® ensures maximum efficacy compared to other devices that only achieve partial innervation. Introducing the tVNS® Triggerbox Launching December 1, 2024, the tVNS® Triggerbox advances neuromodulation research by providing a cable-bound system that minimizes latencies and enhances protocol reproducibility. This key advancement ensures precise, reliable experimental setups for cutting-edge studies. EU-MDR Cla ss IIa Approved Medical Device Our tVNS® E device is the only non-invasive vagus nerve stimulation (VNS) device that is approved as a medical device under the EU-MDR. The supporting comprehensive CB reports not only highlight our device’s safety and efficacy but also facilitate smoother approval processes for your research protocols by ethics committees. EU-MDR Cla ss IIa Cymba Concha Stimulation Benefit from our device’s electrode design, targeting the cymba concha, a method preferred by researchers for its 100% innervation of the auricular branch of the vagus nerve (ABVN). This targeted approach is designed to maximize therapeutic outcomes by engaging the vagus nerve more effectively than other non-invasive methods. EU-MDR Cla ss IIa Wireless Connectivity and Programmability Leverage the power of wireless technology for seamless operation and data management. The tVNS® Research app enables remote programming of stimulation parameters, providing the flexibility needed to adapt to the evolving needs of complex research protocols without interrupting the participant’s experience. EU-MDR Cla ss IIa Made in Germany Trust in the quality and reliability of a device that’s proudly designed and manufactured in Germany. Our commitment to excellence guarantees that every tVNS® device meets the highest standards of performance, durability, and safety, making it the ideal choice for institutions demanding the best in research equipment. EU-MDR Cla ss IIa Titanium-Iridium Electrode Our tVNS® device features titanium-iridium electrodes, most often used in implants and known for their biocompatibility, offering optimal stimulation with minimal irritation. This superior choice sets us apart from stainless steel alternatives, ensuring a more comfortable and effective treatment experience. EU-MDR Cla ss IIa GDPR-Compliant Data Processing With a commitment to privacy and security, our tVNS® system ensures that all data collected through the app is processed in strict adherence to the General Data Protection Regulation (GDPR). Researchers can collect, store, and analyze sensitive data with confidence, knowing that participant privacy is protected. EU-MDR Cla ss IIa Global Network of Trusted Institutions Join an esteemed community of researchers from leading universities and hospitals around the world who have chosen tVNS® for their studies in the global effort to advance neurological research and patient care. EU-MDR Cla ss IIa 20+ Years of Experience With over 20 years of dedicated research and development, we proudly developed the world's first approved non-invasive vagus nerve stimulator, the Cerbomed Nemos® device. Our deep-rooted expertise and pioneering spirit have established us as leaders in the field, committed to delivering groundbreaking and effective solutions for our patients. tVNS® for Research: An Overview Welcome to the frontier of vagus nerve stimulation research. Our tVNS® R device is designed for flexibility and precision, offering full wireless programmability for comprehensive clinical studies. With the tVNS® Research and tVNS® Patient apps, adjustment of stimulation parameters, data collection and patient feedback are seamlessly integrated, enhancing the scope and accuracy of your research. We are committed to facilitating your clinical trials and provide support for studies, including a comprehensive CB safety report for ethics approvals and access to a global network of experts. Explore the potential of tVNS® R to forge new paths in neurological research and patient care. Full Wireless Parameter Programmability and Triggered tVNS® With the tVNS® Research app, you have the capability to wirelessly adjust a comprehensive range of parameters including frequency, pulse width, current intensity, and stimulation intervals. In addition, we offer a separate PC-based tVNS® manager software. This software enables reaction to outside trigger signals (e.g. ECG R-wave trigger generated by an external ECG system, transferred to a PC). Thus, closed loop tVNS® or triggered tVNS® can be realized in a scientific setup. Precision in Research with the tVNS® Triggerbox The new tVNS® Triggerbox, launching December 1, 2024, marks a significant advancement in the field of tVNS® research. Designed in response to feedback from scientific communities, this device addresses the crucial need for more stable and reproducible stimulation protocols in tVNS®. By replacing Bluetooth connections with a cable-bound system, the tVNS® Triggerbox significantly reduces latencies and fluctuations, enabling precise synchronization with external trigger signals. This innovation not only enhances the reliability of experimental setups but also simplifies the integration with existing research frameworks, promising to push the boundaries of tVNS® research further. Research and Patient App Your tVNS® R device gives you access to two apps: the tVNS® Research and tVNS® Patient app. All technical parameters can easily be reprogrammed and wirelessly transmitted with the tVNS® Research app, allowing the researcher to try completely new stimulation protocols. In addition, you can collect and store technical and patient data. The tVNS® Patient app automatically stores all technical data (stimulation parameters, time and duration of the stimulation etc.) and offers a questionnaire for patient feedback. tVNS® Patient is fully compliant with the General Data Protection Regulation (GDPR), ensuring that patient data is handled with the utmost care and confidentiality. Customization and Support for Trials We offer an individual adaptation of all components of the device for certain studies, e.g by changing the questionnaire in order to allow better feedback from the patient, or through the implementation of special stimulation parameters or technical ideas. The tVNS® R device is defined as a device for investigational use. We can provide a CB report that proves the safety according to all medical device standards, in order to assist you with ethics approvals. So far, it has been accepted by all ethics committees. In addition, we offer an international expert network and can direct any questions to experienced people around the world. Legacy and Hook Electrode We offer two different types of electrode designs with our tVNS® devices: The Hook Electrode (left) allows for better fixation and usability during active tasks. It also allows patients to wear earphones. The Legacy Electrode (right) can be used if the patient has small ears or a special ear shape. The integrated slider allows for better adaption to the ear. Sham and fMRI Electrode Options The well-known sham-stimulation option at the earlobe is possible with our Legacy Electrode. Upon request, we also provide more sophisticated sham-stimulation options, as well as fMRI-compatible electrodes. Support for Clinical Trials We offer an individual adaptation of all parts for certain studies, e.g by changing the questionnaire in order to allow better feedback from the patient, or through the implementation of special stimulation parameters or technical ideas. The tVNS® R device is defined as a device for investigational use. We can provide a CB report that proves the safety according to all medical device standards, in order to assist you with ethics approvals. So far, it has been accepted by all ethics committees. In addition, we offer an international expert network and can direct any questions to experienced people around the world. Book a Personal Consultation with our Research Experts Contact our tVNS® Research Team to learn more about tVNS® and receive personalized information and support, such as CB Reports and Instructions for Use (IFU). Name : Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!